Stock ABZENA PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Abzena PLC Stock

Equities

GB00BN65QN46

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Chart Abzena PLC

Dynamic Chart

Press releases Abzena PLC

Abzena : Cancellation - Abzena Plc PU
Abzena : Scheme of Arrangement becomes Effective PU
Abzena : Court sanction of the scheme of arrangement PU
Abzena : Exercise of options PU
Abzena : Form 8.5 (EPT/RI) Abzena Plc PU
More press releases

Managers and Directors - Abzena PLC

Managers TitleAgeSince
Matthew Stober CEO
 Chief Executive Officer 57 22-12-11
Louise Duffy CTO
 Chief Tech/Sci/R&D Officer - 21-09-30
Campbell Bunce CTO
 Chief Tech/Sci/R&D Officer 54 15-10-31
Members of the board TitleAgeSince
Michelle Dawn Neaves BRD
 Director/Board Member 48 18-09-20
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+17.96% 47.02B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 41.76B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 28.8B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.05B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.15B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.55B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.34B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.82B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW